Carbohydrate- and protein-rich diets in McArdle disease: Effects on exercise capacity

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 12, 2008, Pages 1359-1363

  Andersen, S T ^a   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LACTIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; CALORIC INTAKE; CARBOHYDRATE DIET; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; EXERCISE TOLERANCE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 5; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; WORK CAPACITY;

EID: 53049093182     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/adc.2008.146548     Document Type: Article

References (37)

1. Vissing J, Haller RG. Metabolic myopathies. In: Pourmand R, ed. Neuromuscular Diseases: Expert Clinician's Views. Boston: Butterworth-Heinemann. 2001:393-410.
2. DiMauro S, Hays AP, Tsujino S. Nonlysosomal glycogenoses. In: Myology. Engel AG, Franzini-Armstrong C, eds. McGraw-Hill Inc, New York. 2004;1535-8.
3. Felig P, Wahren J. Fuel homeostasis in exercise. N Engl J Med 1975;293:1078-84.
4. Cumming WJK, Hardy M, Hudgson P, et al. Carnitine palmitoyl transferase deficiency. J Neurol Sci 1976;30:247-58.
5. Layzer RB, Havel RJ, McIlroy MB. Partial defiency of carnitine palmitoyltransferase: Physiologic and biochemical consequences. Neurology 1980;30:627-33.
6. Ørngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology 2003;61:559-61.
7. Angelini C, Federico A, Reichmann H, et al. Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders. Eur J Neurol 2006;13:923-9.
8. Slonim AE, Goans PJ. Myopathy in McArdle's syndrome: improvement with high-protein diet. N Engl J Med 1985;312:355-9.
9. 31P magnetic resonance spectroscopy study. Acta Neurol Scand 1990;81:499-503.
10. Haller RG, Wyrick P, Taivassalo T, et al. Aerobic conditioning: An effective therapy in McArdle's disease. Ann Neurol 2006;59:922-8.
11. Mate-Munoz JL, Moran M, Perez M, et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 2007;17:297-303.
12. Wagenmakers AJ. Protein and amino acid metabolism in human muscle. AJV Exp Med Biol 1998;441:307-19.
13. Ørngreen MC, Jeppesen TD, Hauerslev S, et al. Fat metabolism in McArdle's disease. Neuromusc Disord 2006;16(suppl. 1):S157.
14. MacLean D, Vissing J, Vissing SF, et al. Oral branched chain amino acids do not improve exercise capacity in McArdle disease. Neurology 1998;51:1456-9.
15. Haller RG, Vissing J. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle's disease - oxidative mechanisms. Arch Neurol 2002;59:1395-402.
16. Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdles disease. N Engl J Med 2003;349:2503-9.
17. Vissing J, Lewis SF, Galbo H, et al. Effect of deficient muscular glycogenosis on extramuscular fuel production in exercise. J Appl Physiol 1992;72:1773-9.
18. Nielsen JN, Wojtaszewski JFP, Haller RG, et al. Role of 5′AMP-activated protein kinase in glycogen synthase activity and glucose utilization: insights from patients with McArdle's disease. J Physiol 2002;541:979-89.
19. Andersen ST, Dunø M, Schwartz M, et al. Do carriers of PYGM mutations have symptoms of McArdle disease? Neurology 2006;67:716-8.
20. Borg G. Perceived exertion as an indicator of somatic stress. Scan J Rehab Med 1970;2:92-8.
21. Vissing J, MacLean DA, Vissing SF, et al. The exercise metaboreflex is maintained in the absence of muscle acidosis: insights from muscle microdialysis in humans with McArdle's disease. J Physiol 2001;537:641-9.
22. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 2000;31:2751-66.
23. Vogerd M, Zange J, Kley R, et al. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle's disease: double-blind, placebo-controlled crossover study. Arch Neurol 2002;59:97-101.
24. Quinlivan RM, Beynon RJ. Pharmacological and nutritional treatment of McArdle's disease (Glycogen storage disease V). Cochrane Database Syst Rev 2004:3;CD003458.
25. Phoenix J, Hopkins P, Bartram C, et al. Effect of B6 supplementation in McArdle's disease: a strategic case study. Neuromusc Disord 1998;8:210-2.
26. Steele IC, Patterson VH, Nicholls DP. A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease. J Neurol Sci 1996;136:174-7.
27. rd edn. Engel AG, Franzini-Armstrong C (eds). McGraw-Hill Inc, New York. 2004;665-79.
28. Kushner RF, Berman SA. Are high-protein diets effective in McArdle's disease? Arch Neurol 1990;47:383-4.
29. Hopewell R, Yeater R, Ullrich I. The effect of three meals on exercise tolerance of an individual with McArdle's disease. J Am Coll Nutr 1988;6:485-9.
30. Ørngreen MC, Dune M, Christensen E, et al. Fuel utilization in subjects with carnitine palmitoyltransferase II gene mutations. Ann Neurol 2005;57:60-6.
31. Ørngreen MC, Zacho M, Herbert A, et al. Patients with severe muscle wasting are prone to develop hypoglycemia during fasting. Neurology 2003;61:997-1000.
32. Ørngreen MC, Nergaard MG, Sacchetti M, et al. Fuel utilization in patients with very long-chain acyl-CoA dehydrogenase deficiency. Ann Neurol 2004;56:279-82.
33. Vissing J, Haller RG. A diagnostic cycle test for McArdle's disease. Ann Neurol 2003;54:539-42.
34. Sahlin K, Jorfeldt L, Henriksson KG, et al. Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease. Clin Sci (Lond) 1995;88:687-93.
35. Busch V, Gempel K, Hack A, et al. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol 2005;58:341.
36. Viskoper RJ, Wolf E, Chaco J, et al. McArdle's syndrome: the reaction to a fat-rich diet. Am J Med Sci 1975;269:217-21.
37. Carroll JE, DeVivo DC, Rrooke MH, et al. Fasting as a provocative test in neuromuscular diseases. Metabolism 1979;28:683-7.